Kuhn, D. J., Hunsucker, S. A., Chen, Q., Voorhees, P. M., Orlowski, M., & Orlowski, R. Z. (2009). Targeted inhibition of the immunoproteasome is a potent strategy against models of multiple myeloma that overcomes resistance to conventional drugs and nonspecific proteasome inhibitors. American Society of Hematology.

Kuhn, Deborah J., Sally A. Hunsucker, Qing Chen, Peter M. Voorhees, Marian Orlowski, and Robert Z. Orlowski. Targeted Inhibition of the Immunoproteasome Is a Potent Strategy against Models of Multiple Myeloma That Overcomes Resistance to Conventional Drugs and Nonspecific Proteasome Inhibitors. American Society of Hematology, 2009.

Kuhn, Deborah J., et al. Targeted Inhibition of the Immunoproteasome Is a Potent Strategy against Models of Multiple Myeloma That Overcomes Resistance to Conventional Drugs and Nonspecific Proteasome Inhibitors. American Society of Hematology, 2009.